Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Marina P. Kiseleva"'
Autor:
Marina P. Kiseleva, Larisa M. Borisova, Galina B. Smirnova, Yulia A. Borisova, Anna V. Lantsova, Ekaterina V. Sanarova, Lyudmila L. Nikolaeva, Lydia V. Ektova, Marina V. Komarova
Publikováno v:
Research Results in Pharmacology, Vol 8, Iss 2, Pp 49-57 (2022)
Introduction: The creation of highly effective original anticancer drugs remains an urgent direction of scientific research in tumor therapy. One of the promising groups in this regard is indolocarbazoles and their derivatives, which are capable of i
Externí odkaz:
https://doaj.org/article/239417f0b6414ea39f4237f1af680c02
Publikováno v:
Клинический разбор в общей медицине, Vol 4, Iss 12, Pp 25-28 (2024)
Rare breast neoplasms are found by physicians in clinical practice. Phyllodes tumor of the breast accounting for 0.3–1% of all breast neoplasms is one of these neoplasms. Today, the phyllodes tumor etiology is unclear, the same as its pathogenesis.
Externí odkaz:
https://doaj.org/article/9a80b5bbf0054d1daba647259f1e013b
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 9, Pp 19-23 (2024)
In recent decades, the attention of the medical community has increasingly focused on the problems associated with ovarian tumors, especially on the differentiation/difference between borderline tumors and ovarian cancer. These two conditions not onl
Externí odkaz:
https://doaj.org/article/fff0ffc077084d608c58e3883d1cbae2
Autor:
Marina B. Kotova, Vadim N. Kolesnikov, Marina V. Kiseleva, Anton R. Kiselev, Oxana M. Drapkina
Publikováno v:
Discover Mental Health, Vol 4, Iss 1, Pp 1-15 (2024)
Abstract Background In Russia, the following two questionnaires are mainly used to study the burnout syndrome: Maslach Burnout Inventory (MBI) and Boyko’s Burnout Inventory (BBI). Despite the fact that the questionnaires are based on different theo
Externí odkaz:
https://doaj.org/article/b043b434c36b44629633aa2828487f06
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 7, Pp 83-90 (2024)
Borderline ovarian tumors were first infected about 100 years ago. They are detected at an early stage and have a favorable outcome. But, as is known, relapse can begin within 20 years after therapy. Most often they occur in young women who are still
Externí odkaz:
https://doaj.org/article/2534147c63d5434daac177a82afdf482
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 7, Pp 74-82 (2024)
he 2014 World Health Organization classification identifies ovarian seromucinous tumors as one of the six categories of epithelial ovarian tumors. Ovarian seromucinous tumors encompass adenomas, atypical proliferating (borderline) tumors, and invasiv
Externí odkaz:
https://doaj.org/article/ebb29c5d2641432cbefda31a19d9f010
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 3, Pp 68-73 (2024)
Regenerative medicine remains the most rapidly growing and innovative branch of modern medicine. The key substrate of tissue regeneration is the stem cell, which has various differentiation pathways and is the source for various tissue morphotypes. I
Externí odkaz:
https://doaj.org/article/046d207030df4613a6cc07a191370359
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 3, Pp 82-87 (2024)
Over the past decades, there have been great advances in the understanding of serous borderline tumors of the ovary. Although most serous borderline tumors have a favorable outcome, recurrence and progression to carcinoma are possible. Serous borderl
Externí odkaz:
https://doaj.org/article/5323aea2bf5c468699e6f9dd59381ec3
Autor:
Elena V. Litviakova, G.G. Aminov, Maksim S. Denisov, S.A. Ivanov, A.D. Kaprin, Mariia N. Lunkova, Marina V. Kiseleva
Publikováno v:
Клинический разбор в общей медицине, Vol 4, Iss 12, Pp 33-40 (2024)
Thanks to the introduction of new screening programs, the emergence rate of novel anticancer drugs and the detection rate of early-stage breast cancer in Russia increase year by year. Organ preservation treatment, after which radiation therapy has to
Externí odkaz:
https://doaj.org/article/4565118566564a1094aa10891baa253f
Autor:
Elena V. Litvyakova, A.S. Belyakova, Maksim S. Denisov, Mariya N. Lun'kova, I.A. Zharikova, S.A. Ivanov, A.D. Kaprin, Marina V. Kiseleva
Publikováno v:
Клинический разбор в общей медицине, Vol 4, Iss 12, Pp 6-9 (2023)
Today, most of patients with malignant neoplasms are patients with breast cancer, BC (18.3% of all malignant neoplasms). The increase in the diagnosis rate of stage I–II BC is observed since 2011: this indicator was 65% in 2011 and 72.5% in 2021. S
Externí odkaz:
https://doaj.org/article/b69cf82e01b3412eb1609396fa0793dd